According to the company, its Phase 1/2 CLARA trial of AURN001 for corneal edema demonstrated significant dose-dependent ...
Endothelial dysfunction and secondary corneal edema were traditionally considered indications for penetrating keratoplasty (PKP). Nevertheless, the array of post - PKP complications such as suture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback